Fonseca Biosciences Secures Exclusive US Rights to XTORO® (finafloxacin otic suspension) 0.3% to Treat Swimmer’s Ear
Fonseca Biosciences Secures Exclusive US Rights to XTORO® (finafloxacin otic suspension) 0.3% to Treat Swimmer’s Ear
Powered By GrowthZone
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.